Mikhail Rojavin

2.1k total citations
63 papers, 1.6k citations indexed

About

Mikhail Rojavin is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Mikhail Rojavin has authored 63 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 24 papers in Hematology and 14 papers in Genetics. Recurrent topics in Mikhail Rojavin's work include Immunodeficiency and Autoimmune Disorders (31 papers), Platelet Disorders and Treatments (14 papers) and Blood disorders and treatments (12 papers). Mikhail Rojavin is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (31 papers), Platelet Disorders and Treatments (14 papers) and Blood disorders and treatments (12 papers). Mikhail Rojavin collaborates with scholars based in United States, Switzerland and Germany. Mikhail Rojavin's co-authors include Imre Szabó, Thomas J. Rogers, Marvin C. Ziskin, Jeanine L. Bussiere, Martin W. Adler, Alan Cowan, Alexander A. Radzievsky, Richard L. Wasserman, O. Zenker and John‐Philip Lawo and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Journal of Allergy and Clinical Immunology.

In The Last Decade

Mikhail Rojavin

62 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikhail Rojavin United States 23 571 399 350 225 222 63 1.6k
Mikhail V. Ovanesov United States 22 114 0.2× 729 1.8× 183 0.5× 513 2.3× 172 0.8× 57 1.6k
Andreas Bitsch Germany 25 727 1.3× 82 0.2× 68 0.2× 643 2.9× 244 1.1× 48 3.4k
Yasuhiro Maeda Japan 25 947 1.7× 530 1.3× 326 0.9× 620 2.8× 57 0.3× 147 2.6k
Vasilios Kostulas Sweden 28 1.2k 2.0× 58 0.1× 45 0.1× 527 2.3× 212 1.0× 49 2.9k
Douglas Jeffery United States 26 560 1.0× 318 0.8× 46 0.1× 737 3.3× 148 0.7× 84 3.7k
Michael Kuligowski Australia 14 560 1.0× 72 0.2× 80 0.2× 179 0.8× 66 0.3× 17 1.1k
Christopher Moore United Kingdom 25 465 0.8× 72 0.2× 38 0.1× 906 4.0× 64 0.3× 53 2.0k
M. Brai Italy 17 294 0.5× 135 0.3× 131 0.4× 200 0.9× 82 0.4× 41 776
Edwin Walker United States 27 1.2k 2.2× 88 0.2× 54 0.2× 499 2.2× 91 0.4× 65 2.2k
N T Rapson United Kingdom 16 669 1.2× 487 1.2× 367 1.0× 471 2.1× 89 0.4× 25 1.9k

Countries citing papers authored by Mikhail Rojavin

Since Specialization
Citations

This map shows the geographic impact of Mikhail Rojavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikhail Rojavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikhail Rojavin more than expected).

Fields of papers citing papers by Mikhail Rojavin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikhail Rojavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikhail Rojavin. The network helps show where Mikhail Rojavin may publish in the future.

Co-authorship network of co-authors of Mikhail Rojavin

This figure shows the co-authorship network connecting the top 25 collaborators of Mikhail Rojavin. A scholar is included among the top collaborators of Mikhail Rojavin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikhail Rojavin. Mikhail Rojavin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wasserman, Richard L., Charlotte Cunningham‐Rundles, John Anderson, et al.. (2022). Systemic IgG Exposure and Safety in Patients with Primary Immunodeficiency: A Randomized Crossover Study Comparing a Novel Investigational Wearable Infusor Versus the Crono Pump. Immunotherapy. 14(16). 1315–1328. 8 indexed citations
2.
Anderson, John, Vincent R. Bonagura, Juthaporn Cowan, et al.. (2021). Safety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary Immunodeficiency: Findings from the Pump-Assisted Administration Cohorts of the HILO Study. Journal of Clinical Immunology. 41(2). 458–469. 2 indexed citations
3.
Zhang, Ying, et al.. (2019). Population pharmacokinetic analysis of weekly and biweekly IgPro20 (Hizentra®) dosing in patients with primary immunodeficiency. International Immunopharmacology. 81. 106005–106005. 10 indexed citations
4.
Jolles, Stephen, Mikhail Rojavin, John‐Philip Lawo, et al.. (2018). Long-Term Efficacy and Safety of Hizentra® in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 Trials. Journal of Clinical Immunology. 38(8). 864–875. 21 indexed citations
5.
Bygum, Anette, Inmaculada Martinez‐Saguer, Murat Baş, et al.. (2016). Use of a C1 Inhibitor Concentrate in Adults ≥65 Years of Age with Hereditary Angioedema: Findings from the International Berinert® (C1-INH) Registry. Drugs & Aging. 33(11). 819–827. 8 indexed citations
6.
Farkas, Henriette, Lilian Varga, Dumitru Moldovan, et al.. (2016). Assessment of inhibitory antibodies in patients with hereditary angioedema treated with plasma-derived C1 inhibitor. Annals of Allergy Asthma & Immunology. 117(5). 508–513. 6 indexed citations
7.
Busse, Paula J., Anette Bygum, Jonathan M. Edelman, et al.. (2014). Safety of C1-Esterase Inhibitor in Acute and Prophylactic Therapy of Hereditary Angioedema: Findings from the Ongoing International Berinert Patient Registry. The Journal of Allergy and Clinical Immunology In Practice. 3(2). 213–219. 23 indexed citations
8.
Kanegane, Hirokazu, Kohsuke Imai, Masafumi Yamada, et al.. (2014). Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases. Journal of Clinical Immunology. 34(2). 204–211. 28 indexed citations
9.
Borte, Michael, Richard L. Wasserman, Mikhail Rojavin, Martin Bexon, & Stephen Jolles. (2013). Long-Term Efficacy and Tolerability of 20% Scig in the Treatment of Patients with Primary Immunodeficiency Disease. Journal of Allergy and Clinical Immunology. 131(2). AB157–AB157. 1 indexed citations
10.
Craig, Timothy, et al.. (2013). Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks. Annals of Allergy Asthma & Immunology. 111(3). 211–215. 39 indexed citations
11.
Berger, Melvin, Mikhail Rojavin, Peter Kießling, & O. Zenker. (2011). Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies. Clinical Immunology. 139(2). 133–141. 80 indexed citations
12.
Wasserman, Richard L., Isaac Melamed, Robert P. Nelson, et al.. (2011). Pharmacokinetics of Subcutaneous IgPro20 in Patients with Primary Immunodeficiency. Clinical Pharmacokinetics. 50(6). 405–414. 57 indexed citations
13.
Rojavin, Mikhail, et al.. (2006). Factors motivating dyspepsia patients to enter clinical research. Contemporary Clinical Trials. 27(2). 103–111. 10 indexed citations
14.
Tougas, Gervais, et al.. (2005). Omeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod. Alimentary Pharmacology & Therapeutics. 22(1). 59–65. 41 indexed citations
15.
Cowan, Alan, David L. Earnest, Gregory Ligozio, & Mikhail Rojavin. (2005). Omeprazole-induced slowing of gastrointestinal transit in mice can be countered with tegaserod. European Journal of Pharmacology. 517(1-2). 127–131. 14 indexed citations
16.
Radzievsky, Alexander A., et al.. (2001). Peripheral neural system involvement in hypoalgesic effect of electromagnetic millimeter waves. Life Sciences. 68(10). 1143–1151. 35 indexed citations
17.
Radzievsky, Alexander A., et al.. (2000). Hypoalgesic effect of millimeter waves in mice: Dependence on the site of exposure. Life Sciences. 66(21). 2101–2111. 38 indexed citations
18.
Radzievsky, Alexander A., Mikhail Rojavin, Alan Cowan, & Marvin C. Ziskin. (1999). Suppression of Pain Sensation Caused by Millimeter Waves. Anesthesia & Analgesia. 88(4). 836–840. 34 indexed citations
19.
Rojavin, Mikhail & Marvin C. Ziskin. (1995). Effect of millimeter waves on survival of UVC‐exposed Escherichia coli. Bioelectromagnetics. 16(3). 188–196. 22 indexed citations
20.
Rojavin, Mikhail, Imre Szabó, Jeanine L. Bussiere, et al.. (1993). Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages. Life Sciences. 53(12). 997–1006. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mikhail V. Ovanesov Breakdown of academic impact, for papers by Andreas Bitsch Breakdown of academic impact, for papers by Yasuhiro Maeda Breakdown of academic impact, for papers by Vasilios Kostulas Breakdown of academic impact, for papers by Douglas Jeffery Breakdown of academic impact, for papers by Michael Kuligowski Breakdown of academic impact, for papers by Christopher Moore Breakdown of academic impact, for papers by M. Brai Breakdown of academic impact, for papers by Edwin Walker Breakdown of academic impact, for papers by N T Rapson
Rankless by CCL
2026